Rationale for Using of Bifidobacterium Probiotic Strains-Fermented Milk Against Colitis Based on Animal Experiments and Clinical Trials

[1]  J. Doré,et al.  Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients , 2008, Proceedings of the National Academy of Sciences.

[2]  H. Ogata,et al.  Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease. , 2008, International journal of medical microbiology : IJMM.

[3]  S. Mazmanian,et al.  A microbial symbiosis factor prevents intestinal inflammatory disease , 2008, Nature.

[4]  T. Shima,et al.  Anti-inflammatory activity of probiotic Bifidobacterium: enhancement of IL-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of IL-8 secretion in HT-29 cells. , 2008, World journal of gastroenterology.

[5]  R. Baldassano,et al.  Lamina Propria and Circulating Interleukin-8 in Newly and Previously Diagnosed Pediatric Inflammatory Bowel Disease Patients , 2007, Digestive Diseases and Sciences.

[6]  H. Lochs,et al.  Spatial Organization and Composition of the Mucosal Flora in Patients with Inflammatory Bowel Disease , 2005, Journal of Clinical Microbiology.

[7]  E. Purdom,et al.  Diversity of the Human Intestinal Microbial Flora , 2005, Science.

[8]  A. Imaoka,et al.  Randomized placebo‐controlled trial assessing the effect of bifidobacteria‐fermented milk on active ulcerative colitis , 2004, Alimentary pharmacology & therapeutics.

[9]  Ruslan Medzhitov,et al.  Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis , 2004, Cell.

[10]  G. Macfarlane,et al.  Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn’s disease differentially activate the innate immune response , 2003, Gut.

[11]  H. Ishikawa,et al.  Randomized Controlled Trial of the Effect of Bifidobacteria-Fermented Milk on Ulcerative Colitis , 2003, Journal of the American College of Nutrition.

[12]  H. Ishikawa,et al.  Prevention of gut inflammation by Bifidobacterium in dextran sulfate-treated gnotobiotic mice associated with Bacteroides strains isolated from ulcerative colitis patients. , 2003, Microbes and infection.

[13]  T. Ohkusa,et al.  Fusobacterium varium localized in the colonic mucosa of patients with ulcerative colitis stimulates species‐specific antibody , 2002, Journal of gastroenterology and hepatology.

[14]  A. Imaoka,et al.  Preventive Effects of Bifidobacterium- and Lactobacillus-Fermented Milk on the Development of Inflammatory Bowel Disease in Senescence-Accelerated Mouse P1/Yit Strain Mice , 2001, Digestion.

[15]  Y. Umesaki,et al.  Structure of the intestinal flora responsible for development of the gut immune system in a rodent model. , 2000, Microbes and infection.

[16]  D. Rennick,et al.  XII. IL-10-deficient (IL-10− / −) mice and intestinal inflammation * , 2000 .

[17]  A. Andoh,et al.  Characterization of antibody responses against rectal mucosa‐associated bacterial flora in patients with ulcerative colitis , 2000, Journal of gastroenterology and hepatology.

[18]  Y. Umesaki,et al.  Enteric Bacteria and Their Roles in Inflammatory Bowel Disease , 1999 .

[19]  A. Imaoka,et al.  Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse P1/Yit strain , 1998, Gut.

[20]  K. Tamura,et al.  Mucosal blood flow and generation of superoxide in rat experimental colitis induced by succinic acid , 1997, Journal of Gastroenterology.

[21]  R. Tanaka,et al.  Early administration of Bifidobacterium breve to preterm infants: randomised controlled trial , 1997, Archives of disease in childhood. Fetal and neonatal edition.

[22]  R. Hammer,et al.  Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. , 1996, The Journal of clinical investigation.

[23]  A. Imaoka,et al.  Segmented Filamentous Bacteria Are Indigenous Intestinal Bacteria That Activate Intraepithelial Lymphocytes and Induce MHC Class II Molecules and Fucosyl Asialo GM1 Glycolipids on the Small Intestinal Epithelial Cells in the Ex‐Germ‐Free Mouse , 1995, Microbiology and immunology.

[24]  S. Hanauer,et al.  Cyclosporine in severe ulcerative colitis refractory to steroid therapy. , 1994, The New England journal of medicine.

[25]  S. Tonegawa,et al.  Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice , 1993, Cell.

[26]  A. Feller,et al.  Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene , 1993, Cell.

[27]  K. Rajewsky,et al.  Interleukin-10-deficient mice develop chronic enterocolitis , 1993, Cell.

[28]  T. Kirchner,et al.  Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. , 1992, Gastroenterology.

[29]  K. Sunakawa,et al.  Clinical effects of Bifidobacterium preparations on pediatric intractable diarrhea. , 1987, The Keio journal of medicine.

[30]  Y. Umesaki.  Immunohistochemical and biochemical demonstration of the change in glycolipid composition of the intestinal epithelial cell surface in mice in relation to epithelial cell differentiation and bacterial association. , 1984, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[31]  Y. Umesaki,et al.  Abrupt induction of GDP-fucose: asialo GM1 fucosyltransferase in the small intestine after conventionalization of germ-free mice. , 1982, Biochemical and biophysical research communications.

[32]  Wangxue Chen,et al.  The intestinal microflora and inflammatory bowel disease , 1999 .

[33]  Y. Umesaki,et al.  Expansion of alpha beta T-cell receptor-bearing intestinal intraepithelial lymphocytes after microbial colonization in germ-free mice and its independence from thymus. , 1993, Immunology.